Engagement of 4-1BB Inhibits the Development of Experimental Allergic Conjunctivitis in Mice

DOI PDF PubMed 被引用文献4件 オープンアクセス
  • Atsuki Fukushima
    Department of Ophthalmology, Kochi Medical School , Nankoku-city ,
  • Tomoko Yamaguchi
    Department of Ophthalmology, Kochi Medical School , Nankoku-city ,
  • Waka Ishida
    Department of Ophthalmology, Kochi Medical School , Nankoku-city ,
  • Kazuyo Fukata
    Department of Ophthalmology, Kochi Medical School , Nankoku-city ,
  • Robert S Mittler
    Department of Surgery and Emory Vaccine Center, Emory University School of Medicine , Atlanta, GA 30329
  • Hideo Yagita
    Department of Immunology, School of Medicine, Juntendo University , Tokyo ,
  • Hisayuki Ueno
    Department of Ophthalmology, Kochi Medical School , Nankoku-city ,

書誌事項

公開日
2005-10
権利情報
  • https://academic.oup.com/pages/standard-publication-reuse-rights
DOI
  • 10.4049/jimmunol.175.8.4897
公開者
Oxford University Press (OUP)

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p>The 4-1BB receptor acts as a costimulator in CD8+ T cell activation. Agonistic stimulation through this molecule by treatment with anti-4-1BB Abs has been demonstrated to inhibit various experimentally induced diseases in animals. However, the effect of anti-4-1BB Abs on experimental allergic diseases has not been reported. We investigated the effect of anti-4-1BB Abs on the development and progression of experimental allergic conjunctivitis in mice. To examine the effects of Abs during the induction or effector phase, actively immunized mice or passively immunized mice by splenocyte transfer were treated with agonistic anti-4-1BB Abs, blocking anti-4-1BB ligand Abs, or normal rat IgG. Eosinophil infiltration into the conjunctiva was significantly reduced in wild-type mice by the anti-4-1BB Ab treatment during either induction or effector phase. Th2 cytokine production by splenocytes and total serum IgE were significantly reduced by the anti-4-1BB Ab treatment, while IFN-γ production was increased. The anti-4-1BB Ab treatment induced a relative increase of CD8-positive cell numbers in the spleens. Moreover, inhibition of eosinophil infiltration by the treatment with anti-4-1BB Abs was also noted in actively immunized IFN-γ knockout mice. Taken altogether, in vivo treatment with agonistic anti-4-1BB Abs in either induction or effector phase inhibits the development of experimental allergic conjunctivitis, and this inhibition is likely to be mediated by suppression of Th2 immune responses rather than up-regulation of IFN-γ.</jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ